Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / House Bills / H.R. 7667

H.R. 7667

To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

Print stageDateSize⠃
Introduced in House2022-05-06179.1K⠃⠗⠋
Reported in House2022-06-07190.1K⠃⠗⠋
Engrossed in House—202.6K⠃⠗⠋
rds2022-06-09202.2K⠃⠗⠋